LABCORP HOLDINGS INC. Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations
LABCORP HOLDINGS INC. (LH) reported Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations · last filed 2026-02-24
- LABCORP HOLDINGS INC. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for the quarter ending 2017-03-31 was $6.20M, a 23.46% decline year-over-year.
- LABCORP HOLDINGS INC. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for the quarter ending 2016-03-31 was $8.10M, a 58.82% increase year-over-year.
- LABCORP HOLDINGS INC. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for the quarter ending 2015-03-31 was $5.10M, a 42.70% decline year-over-year.
- LABCORP HOLDINGS INC. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for the quarter ending 2014-03-31 was $8.90M.
- LABCORP HOLDINGS INC. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- LABCORP HOLDINGS INC. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2024 was $200.00K, a 97.67% decline from fiscal 2023.
- LABCORP HOLDINGS INC. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2023 was $8.60M, a 109.76% increase from fiscal 2022.
- LABCORP HOLDINGS INC. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2022 was $4.10M, a 105.00% increase from fiscal 2021.
| Period end | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 3 month | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 12 month | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 12 month as first filed |
|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-24 | ||
| 2024-12-31 | $200.00K 10-K · filed 2026-02-24 | ||
| 2023-12-31 | $8.60M 10-K · filed 2026-02-24 | ||
| 2022-12-31 | $4.10M 10-K · filed 2025-02-25 | $7.30M 10-K · filed 2023-02-28 | |
| 2021-12-31 | $2.00M 10-K · filed 2024-02-26 | $20.40M 10-K · filed 2022-02-25 | |
| 2020-12-31 | $8.10M 10-K · filed 2023-02-28 | ||
| 2019-12-31 | $4.20M 10-K · filed 2022-02-25 | ||
| 2018-12-31 | $0.00 10-K · filed 2021-02-25 | ||
| 2017-12-31 | $6.20M 10-K · filed 2020-02-28 | ||
| 2017-03-31 | $6.20M 10-K · filed 2019-02-28 | ||
| 2016-12-31 | $8.10M 10-K · filed 2017-02-27 | ||
| 2016-03-31 | $8.10M 10-K · filed 2019-02-28 | ||
| 2015-12-31 | $5.10M 10-K · filed 2017-02-27 | ||
| 2015-03-31 | $5.10M 10-K · filed 2018-02-27 | ||
| 2014-12-31 | $8.90M 10-K · filed 2016-03-01 | ||
| 2014-03-31 | $8.90M 10-K · filed 2017-02-27 | ||
| 2013-12-31 | $8.30M 10-K · filed 2016-03-01 | ||
| 2012-12-31 | $8.60M 10-K · filed 2015-02-26 | ||
| 2011-12-31 | $9.30M 10-K · filed 2014-02-25 | ||
| 2010-12-31 | $12.60M 10-K · filed 2013-02-26 | -$12.60M 10-K/A · filed 2011-03-07 | |
| 2009-12-31 | $4.50M 10-K · filed 2012-02-24 | -$4.50M 10-K/A · filed 2011-03-07 | |
| 2008-12-31 | -$1.20M 10-K/A · filed 2011-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |